Moonbase
← Back to Awards
NATIONAL HEART, LUNG, AND BLOOD INSTITUTENIH · NATIONAL HEART, LUNG, AND BLOOD INSTITUTENIH

Role of Piezo1-controlled Prox1 Modification in Lymphatic Valve Formation

Choi, Dongwon (Contact)·UNIVERSITY OF SOUTHERN CALIFORNIA, CA·2025–2029·ACTIVE
Donate

INSTITUTION

UNIVERSITY OF SOUTHERN CALIFORNIA, CA

PRINCIPAL INVESTIGATOR

Choi, Dongwon (Contact)

FUNDING

$808K

YEAR

2025

MOONBASE SCORE

Still being scored

LOADING MOONBASE SCORE

Abstract

PROGRAM SUMMARY Our proposal aims to elucidate how lymphatic endothelial cells detect external fluid forces and convert these signals into a biological program that orchestrates lymphatic valve formation. We are particularly focused on the role of Piezo1, a mechanosensitive ion channel in lymphatic endothelial cells, in sensing bidirectional oscillatory fluid flow and activating downstream effectors. This activation leads to a post-translational modification of Prox1, the homeodomain transcription factor critical for lymphatic development. We hypothesize that this specific modification of Prox1 is essential for the formation of lymphatic and lymphovenous valves, as the modification alters its transcriptional activity by affecting protein stability and binding affinity with partners. The primary goal of this project is to deepen our understanding of how Prox1 activity is influenced by mechanical stimuli and to understand the functional implications of these modifications in lymphatic valve development. Our approach will incorporate a range of methods including in vitro experiments, ex vivo assays, and innovative animal models, including mutant and transgenic mice, to test the central hypothesis. This research seeks to uncover the essential molecular mechanisms that control lymphatic development and may identify new therapeutic targets for treating lymphatic-related disorders. We anticipate that our findings will provide fresh insights into the molecular underpinnings of lymphatic anomalies and valve dysfunctions, potentially offering the development of targeted treatments for lymphatic malformations and other related vascular conditions.

NATIONAL HEART, LUNG, AND BLOOD INSTITUTER01Special Emphasis Panel[ZRG1 CDD-Q (81)]understandingmodelsmechanicalcentralaffectingleadsunderstandidentifyfactormodificationtranscriptionalsummarysfdtreatinginnovativebidirectionaltranslationalconditionsvitro

Are you the primary organization running this research?

The two tools below are built for the principal investigator & host institution behind this project.